News

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
BioPharma Dive7m
Moderna COVID vaccine gets full approval for children
The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...
Asianet Newsable on MSN25m
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
Moderna’s shares were up nearly 3% at the time of writing. The vaccine was previously available for pediatric populations ...